Hematopoietic Stem Cell Transplantation
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients [Phase 3]
Phase 3 trial evaluating the safety and efficacy of N-Acetylcysteine mouthwash to prevent mucositis in patients undergoing hematopoietic ste…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Compassionate Access of the Miltenyi Device for CD34+ Cell Selection [NA]
The trial update notes compassionate-access to Miltenyi's CD34+ cell selection device for hematopoietic stem cell transplantation, with recr…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
This is a prospective registry enrolling pediatric patients undergoing cellular therapy related to hematopoietic stem cell transplantation t…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD
A clinical trial is evaluating posaconazole tablets as primary prophylaxis against invasive fungal disease in hematopoietic stem cell transp…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients [NA]
Clinical trial update describes recruitment for a study evaluating mesenchymal stem cell supernatant to prevent and treat skin and mucosal i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-06-15Clinical Trial Update: Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation [Phase 2]
Phase 2 clinical trial evaluating maraviroc-based prophylaxis to prevent graft-versus-host disease after hematopoietic stem cell transplanta…